The present invention provides compounds of formula I ##STR00001## and
pharmaceutically acceptable salts thereof.The compounds of the invention
inhibit tyrosine kinase activity of growth factor receptors such as HER1,
HER2 and HER4 thereby making them useful as antiproliferative agents for
the treatment of cancer and other diseases.